TY - JOUR
T1 - Dementia clinical trial implications of mild behavioral impairment
AU - Mortby, Moyra E.
AU - Black, Sandra E.
AU - Gauthier, Serge
AU - Miller, David
AU - Porsteinßon, Anton
AU - Smith, Eric E.
AU - Ismail, Zahinoor
PY - 2018/2/1
Y1 - 2018/2/1
N2 - The World Alzheimer Report 2016 estimated that 47 million people are living with dementia worldwide (Alzheimer's Disease International, 2016). In the inaugural World Health Organization Ministerial Conference on Global Action against Dementia, six of the top ten research priorities were focused on prevention, identification, and reduction of dementia risk, and on delivery and quality of care for people with dementia and their carers (Shah et al., 2016). While the Lancet Neurology Commission has suggested that even minor advances to delay progression or ameliorate symptoms might have substantial financial and societal benefits (Winblad et al., 2016), advances have been slow.
AB - The World Alzheimer Report 2016 estimated that 47 million people are living with dementia worldwide (Alzheimer's Disease International, 2016). In the inaugural World Health Organization Ministerial Conference on Global Action against Dementia, six of the top ten research priorities were focused on prevention, identification, and reduction of dementia risk, and on delivery and quality of care for people with dementia and their carers (Shah et al., 2016). While the Lancet Neurology Commission has suggested that even minor advances to delay progression or ameliorate symptoms might have substantial financial and societal benefits (Winblad et al., 2016), advances have been slow.
UR - http://www.scopus.com/inward/record.url?scp=85053632704&partnerID=8YFLogxK
U2 - 10.1017/S1041610218000042
DO - 10.1017/S1041610218000042
M3 - Comment/debate
SN - 1041-6102
VL - 30
SP - 171
EP - 175
JO - International Psychogeriatrics
JF - International Psychogeriatrics
IS - 2
ER -